Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Alderson

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Trials|July 8, 2022
Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary careSarah L Alderson, Alexandra Wright-Hughes, Alexander C Ford, et al.
The Journal of Experimental Medicine|October 2, 2013
Aging predisposes to acute inflammatory induced pathology after tumor immunotherapyMyriam N Bouchlaka, Gail D Sckisel, Mingyi Chen, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 27, 2024
Low-dose amitriptyline for irritable bowel syndrome: a qualitative study of patients' and GPs' views and experiencesEmma J Teasdale, Hazel A Everitt, Sarah L Alderson, et al.
Health Technology Assessment (Winchester, England)|October 14, 2024
Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCTAlexandra Wright-Hughes, Alexander C Ford, Sarah L Alderson, et al.
Lancet (London, England)|October 20, 2023
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trialAlexander C Ford, Alexandra Wright-Hughes, Sarah L Alderson, et al.
European Heart Journal|March 12, 2019
Associations between vascular risk factors and brain MRI indices in UK BiobankSimon R Cox, Donald M Lyall, Stuart J Ritchie, et al.
The Journal of Heredity|June 3, 2006
Genetic diversity analysis using lowly polymorphic dominant markers: the example of AFLP in pigsJ-L Foulley, M G M van Schriek, L Alderson, et al.
Animal Genetics|June 1, 2006
Genetic diversity within and between European pig breeds using microsatellite markersM SanCristobal, C Chevalet, C S Haley, et al.
Animal Genetics|June 1, 2006
Genetic diversity in European pigs utilizing amplified fragment length polymorphism markersM SanCristobal, C Chevalet, J Peleman, et al.
Nature|January 9, 2023
Early Release Science of the exoplanet WASP-39b with JWST NIRSpec PRISMZ Rustamkulov, D K Sing, S Mukherjee, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Trials|July 8, 2022
Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary careSarah L Alderson, Alexandra Wright-Hughes, Alexander C Ford, et al.
The Journal of Experimental Medicine|October 2, 2013
Aging predisposes to acute inflammatory induced pathology after tumor immunotherapyMyriam N Bouchlaka, Gail D Sckisel, Mingyi Chen, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|August 27, 2024
Low-dose amitriptyline for irritable bowel syndrome: a qualitative study of patients' and GPs' views and experiencesEmma J Teasdale, Hazel A Everitt, Sarah L Alderson, et al.
Health Technology Assessment (Winchester, England)|October 14, 2024
Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCTAlexandra Wright-Hughes, Alexander C Ford, Sarah L Alderson, et al.
Lancet (London, England)|October 20, 2023
Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trialAlexander C Ford, Alexandra Wright-Hughes, Sarah L Alderson, et al.
European Heart Journal|March 12, 2019
Associations between vascular risk factors and brain MRI indices in UK BiobankSimon R Cox, Donald M Lyall, Stuart J Ritchie, et al.
The Journal of Heredity|June 3, 2006
Genetic diversity analysis using lowly polymorphic dominant markers: the example of AFLP in pigsJ-L Foulley, M G M van Schriek, L Alderson, et al.
Animal Genetics|June 1, 2006
Genetic diversity within and between European pig breeds using microsatellite markersM SanCristobal, C Chevalet, C S Haley, et al.
Animal Genetics|June 1, 2006
Genetic diversity in European pigs utilizing amplified fragment length polymorphism markersM SanCristobal, C Chevalet, J Peleman, et al.
Nature|January 9, 2023
Early Release Science of the exoplanet WASP-39b with JWST NIRSpec PRISMZ Rustamkulov, D K Sing, S Mukherjee, et al.
Pageof 15